Literature DB >> 34951444

A Randomized Clinical Trial Demonstrating Feasibility and Preliminary Efficacy of a Videoconference-Delivered Physical Activity Lifestyle Intervention Among Adolescents With a Congenital Heart Defect.

Jamie L Jackson1,2, Kristen R Fox1, Joseph R Rausch1,2, Taylor N Swenski1, Steven P Neville1, Noelle C Marousis1, Christina X Korth1, Clifford L Cua3, Vidu Garg2,3,4, Kathryn Vannatta1,2.   

Abstract

BACKGROUND: Individuals with congenital heart defects are at increased risk for developing further cardiovascular complications, which can be mitigated by increasing physical activity. Given that positive health behaviors begin declining during older adolescence, it is vital to promote lifestyle changes in this population.
PURPOSE: The current study aims to (a) determine the feasibility/acceptability of the Congenital Heart Disease Physical Activity Lifestyle (CHD-PAL) intervention among adolescents (ages 15-18) with moderate and complex congenital heart defects, and (b) estimate the preliminary efficacy of CHD-PAL for increasing time spent in moderate-to-vigorous physical activity (MVPA) and cardiorespiratory fitness and decreasing sedentary behavior.
METHODS: Eligible participants were randomized into either CHD-PAL (eight 30-min videoconferencing sessions over 20 weeks with an interventionist + Fitbit + exercise prescription) or a comparator (Fitbit + exercise prescription).
RESULTS: Sixty adolescents were randomized (76% recruitment rate; 94% of participants were retained from baseline to follow-up). Most adolescents (73%) and their parents/guardians (76%) reported that the trial was enjoyable. While there was no effect of arm on change in MVPA, sedentary behavior, or cardiorespiratory fitness for the entire sample, among those who engaged in <21 min of MVPA on average at baseline, adolescents in the CHD-PAL intervention had an increase of 16 min/day of MVPA more than comparators (d = 0.90).
CONCLUSIONS: The CHD-PAL intervention warrants examination in a larger trial to establish efficacy among those adolescents with a congenital heart defect who engage in <21 min of MVPA/day and should include follow-up assessments to examine effect durability. CLINICAL TRIALS REGISTRATION: NCT03335475. © Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Adolescents; Congenital heart disease; Physical activity; Randomized clinical trial

Mesh:

Year:  2022        PMID: 34951444      PMCID: PMC9274981          DOI: 10.1093/abm/kaab105

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  43 in total

1.  Changing the behavior of healthcare professionals: the use of theory in promoting the uptake of research findings.

Authors:  Martin Eccles; Jeremy Grimshaw; Anne Walker; Marie Johnston; Nigel Pitts
Journal:  J Clin Epidemiol       Date:  2005-02       Impact factor: 6.437

2.  Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium.

Authors:  Philip Moons; Lore Bovijn; Werner Budts; Ann Belmans; Marc Gewillig
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

3.  Calibration of two objective measures of physical activity for children.

Authors:  Kelly R Evenson; Diane J Catellier; Karminder Gill; Kristin S Ondrak; Robert G McMurray
Journal:  J Sports Sci       Date:  2008-12       Impact factor: 3.337

Review 4.  Position statement on physical activity and exercise intensity terminology.

Authors:  Kevin Norton; Lynda Norton; Daryl Sadgrove
Journal:  J Sci Med Sport       Date:  2009-12-10       Impact factor: 4.319

5.  A Theory of Planned Behavior-Based Program to Increase Physical Activity in Overweight/Obese Military Personnel: A Randomised Controlled Trial.

Authors:  Hormoz Sanaeinasab; Mohsen Saffari; Mohammad-Ali Dashtaki; Amir H Pakpour; Aliakbar Karimi Zarchi; Keisha-Gaye N O'Garo; Harold G Koenig
Journal:  Appl Psychol Health Well Being       Date:  2019-07-28

6.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

7.  Design and rationale for the PREVAIL study: effect of e-Health individually tailored encouragements to physical exercise on aerobic fitness among adolescents with congenital heart disease--a randomized clinical trial.

Authors:  Susanne Hwiid Klausen; Ulla Ramer Mikkelsen; Asle Hirth; Jørn Wetterslev; Hanne Kjærgaard; Lars Søndergaard; Lars Louis Andersen
Journal:  Am Heart J       Date:  2012-04       Impact factor: 4.749

Review 8.  Hypertension, obesity, and coronary artery disease in the survivors of congenital heart disease.

Authors:  S Lucy Roche; Candice K Silversides
Journal:  Can J Cardiol       Date:  2013-05-18       Impact factor: 5.223

9.  Transforming growth factor β1 and coronary intimal hyperplasia in pediatric patients with congenital heart disease.

Authors:  Roberto A Guerri-Guttenberg; Rocío Castilla; Gabriela C Francos; Angélica Müller; Giuseppe Ambrosio; José Milei
Journal:  Can J Cardiol       Date:  2013-02-06       Impact factor: 5.223

10.  Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010.

Authors:  Suzanne M Gilboa; Owen J Devine; James E Kucik; Matthew E Oster; Tiffany Riehle-Colarusso; Wendy N Nembhard; Ping Xu; Adolfo Correa; Kathy Jenkins; Ariane J Marelli
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.